期刊文献+

CD_(44V6)在宫颈癌中的表达及其与转移和预后的关系 被引量:1

Expression of CD_(44V6) protein in invasive carcinoma of cervix and its significance
暂未订购
导出
摘要 目的 探讨CD44V6在宫颈癌中表达与肿瘤转移及患者预后的关系。方法 应用免疫组化方法检测15例正常宫颈组织、30例宫颈上皮瘤样病变、58例浸润宫颈癌中CD44V6蛋白表达。结果 CD44V6阳性表达在正常宫颈组织、宫颈上皮瘤样病变及浸润宫颈癌呈逐渐增高趋势,宫颈上皮瘤样病变及浸润宫颈癌CD44V6蛋白阳性表达与正常宫颈组织比较有显著性差异(P<0.05)。CD44V6蛋白在浸润型宫颈癌阳性表达明显高于宫颈上皮瘤样病变(P<0.05)。浸润型宫颈癌CD44V6蛋白表达与患者的年龄、肿瘤大小、组织分级、预后无关,CD44V6蛋白阳性表达与有无淋巴结转移密切相关(P<0.05),浸润深度≥1cn CD44V6蛋白阳性表达明显高于浸润深度<1cm (P<0.05),Ⅱ期宫颈癌中CD44V6蛋白表达明显高于Ⅰ期(P<0.05)。结论 CD44V6在宫颈癌的发生、发展中起重作用,并且与肿瘤的浸润转移密切相关,可作为临床预测浸润转移的一个重要参考指标。 Objective To study the expressive of CD44V6 protein in invasive carcinoma of cervix and its significance.Methods The expression of Cd44V6 protein of 15 normal cervial epithelium (NCE),30 cervical intraepithelium neoplasia (CIN),58 invasive carcinoma of cervix (ICC) were detected by immunohistochemical method.Results 1. The positive expression of CD44V6 in CIN and ICC was significantly different to that of in NCE (P<0.05).2. The positive expression of CD44V6 in CIN was significantly different from that of in ICC (P < 0.05) .2. The was no significant correlation between CD44V6 and patient age,tumor size,tumor differentiation and prognosis ( P < 0.05) 3. There was significant correlation between CD44V6 and lymph nodes metastasis,invasive depth ( P < 0.05) .4. The positive expression of CD44V6 in stage Ⅱ was significantly higher than that in stage I . There was significantly difference ( P < 0.05).Conclusion There was a close correlation between expression of CD44V6 and generation and development in the ICC. The expression of CD44V6 may serve as an indicator to predict the invasion and lymph nodes metastasis of invasive carcinoma of cervix.
出处 《实用肿瘤学杂志》 CAS 2004年第2期104-106,共3页 Practical Oncology Journal
关键词 CD44V6 宫颈癌 表达 转移 预后 Carcinoma of cervk CD44V6 Immunohistochemistry
  • 相关文献

参考文献5

  • 1Lokesh war VB, Bourguigcn LY. The lymphoma transmembrane glyocoprotein GP85 (CD44V) is a novel gananine nucleotide-binding protein with regnlates GP85 ( CD44v )-ankyrin interaction. J Biol chem, 1992;267: 22073 ~ 22078
  • 2Iida N, Bourguignon LYW New CD44V splice variants associated with humanbreast cancer. J Cell Physiol, 1995; 102:127
  • 3Dali P, Heider KH, Hekele A, et al. Surface protein exqression and mRNA-splicing analysis of CD44V in uterine cervical cancer and normal cervical epithelium. Cancer Res, 1994;54(13):3337
  • 4Kainz CH, Kohberger P, Sliutz G, et al. Splice variants of CD44V in human cervical cancer stage. Gynecol Oncol, 1995;57(3:383)
  • 5Ayhan A, BaykaL C. Altered CD44V variant 6 expression in FIGO stage IB cervical carcinoma. Gynecol Oncol, 2001; 83 (3): 569 - 574

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部